Unknown

Dataset Information

0

The crosstalk of mTOR/S6K1 and Hedgehog pathways.

ABSTRACT: Esophageal adenocarcinoma (EAC) is the most prevalent esophageal cancer type in the United States. The TNF-?/mTOR pathway is known to mediate the development of EAC. Additionally, aberrant activation of Gli1, downstream effector of the Hedgehog (HH) pathway, has been observed in EAC. In this study, we found that an activated mTOR/S6K1 pathway promotes Gli1 transcriptional activity and oncogenic function through S6K1-mediated Gli1 phosphorylation at Ser84, which releases Gli1 from its endogenous inhibitor, SuFu. Moreover, elimination of S6K1 activation by an mTOR pathway inhibitor enhances the killing effects of the HH pathway inhibitor. Together, our results established a crosstalk between the mTOR/S6K1 and HH pathways, which provides a mechanism for SMO-independent Gli1 activation and also a rationale for combination therapy for EAC.

SUBMITTER: Wang Y 

PROVIDER: S-EPMC3350095 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Esophageal adenocarcinoma (EAC) is the most prevalent esophageal cancer type in the United States. The TNF-α/mTOR pathway is known to mediate the development of EAC. Additionally, aberrant activation of Gli1, downstream effector of the Hedgehog (HH) pathway, has been observed in EAC. In this study, we found that an activated mTOR/S6K1 pathway promotes Gli1 transcriptional activity and oncogenic function through S6K1-mediated Gli1 phosphorylation at Ser84, which releases Gli1 from its endogenous  ...[more]

Similar Datasets

Unknown Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways.
| S-EPMC3046835 | biostudies-literature
Unknown Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways.
| S-EPMC4891118 | biostudies-literature
Unknown Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch.
| S-EPMC3552917 | biostudies-literature
Unknown Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
| S-EPMC4366884 | biostudies-other
Unknown S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.
| S-EPMC3175787 | biostudies-literature
Unknown Analysis of crosstalk between retinoic acid and sonic hedgehog pathways following ethanol exposure in embryonic zebrafish.
| S-EPMC4697881 | biostudies-literature
Unknown Mutations in the sonic hedgehog pathway cause macrocephaly-associated conditions due to crosstalk to the PI3K/AKT/mTOR pathway.
| S-EPMC7346528 | biostudies-literature
Unknown Signaling crosstalk between the mTOR complexes.
| S-EPMC4705829 | biostudies-other
Unknown U12, a UDCA derivative, acts as an anti-hepatoma drug lead and inhibits the mTOR/S6K1 and cyclin/CDK complex pathways.
| S-EPMC4259312 | biostudies-literature
Unknown Icariside II promotes the osteogenic differentiation of canine bone marrow mesenchymal stem cells via the PI3K/AKT/mTOR/S6K1 signaling pathways.
| S-EPMC5446494 | biostudies-literature